COMBINATION OF IBRUTINIB WITH RITUXIMAB (IR) IS HIGHLY EFFECTIVE IN PREVIOUSLY UNTREATED ELDERLY (>65 YEARS) PATIENTS (PTS) WITH MANTLE CELL LYMPHOMA (MCL) – PHASE II TRIAL
Saved in:
Published in | Hematological oncology Vol. 37; no. S2; p. 42 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester
Wiley Subscription Services, Inc
01.06.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
ISSN: | 0278-0232 1099-1069 |
---|---|
DOI: | 10.1002/hon.11_2629 |